blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3178814

EP3178814 - METHOD FOR PRODUCING PYRIMIDIN-1-OL COMPOUND, AND INTERMEDIATE THEREOF [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  14.02.2020
Database last updated on 20.05.2024
FormerThe patent has been granted
Status updated on  08.03.2019
FormerGrant of patent is intended
Status updated on  26.11.2018
FormerRequest for examination was made
Status updated on  12.05.2017
FormerThe international publication has been made
Status updated on  28.12.2016
Most recent event   Tooltip08.07.2022Lapse of the patent in a contracting state
New state(s): MK		published on 10.08.2022  [2022/32]
Applicant(s)For all designated states
Eisai R&D Management Co., Ltd.
6-10, Koishikawa 4-chome Bunkyo-ku
Tokyo 112-8088 / JP
[2017/24]
Inventor(s)01 / WATANABE, Yuzo
c/o Eisai Co. Ltd.
Kashima Plant
22 Sunayama
Kamisu-shi Ibaraki 314-0255 / JP
 [2017/24]
Representative(s)Hoffmann Eitle
Patent- und Rechtsanwälte PartmbB
Arabellastraße 30
81925 München / DE
[2017/24]
Application number, filing date15829152.603.08.2015
[2017/24]
WO2015JP71930
Priority number, dateUS201462033665P06.08.2014         Original published format: US 201462033665 P
[2017/24]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2016021539
Date:11.02.2016
Language:JA
[2016/06]
Type: A1 Application with search report 
No.:EP3178814
Date:14.06.2017
Language:EN
[2017/24]
Type: B1 Patent specification 
No.:EP3178814
Date:10.04.2019
Language:EN
[2019/15]
Search report(s)International search report - published on:JP11.02.2016
(Supplementary) European search report - dispatched on:EP05.03.2018
ClassificationIPC:C07D239/36, C07D239/34
[2017/24]
CPC:
C07D239/34 (EP,IL,RU,US); C07D239/36 (EP,IL,KR,RU,US); A61K31/505 (KR)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2017/24]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
TitleGerman:VERFAHREN ZUR HERSTELLUNG EINER PYRIMIDIN-1-OL-VERBINDUNG UND ZWISCHENPRODUKT DARAUS[2017/24]
English:METHOD FOR PRODUCING PYRIMIDIN-1-OL COMPOUND, AND INTERMEDIATE THEREOF[2017/24]
French:PROCÉDÉ DE FABRICATION DE COMPOSÉ PYRIMIDINE-1-OL, ET INTERMÉDIAIRE DE CELUI-CI[2017/24]
Entry into regional phase28.12.2016Translation filed 
28.12.2016National basic fee paid 
28.12.2016Search fee paid 
28.12.2016Designation fee(s) paid 
28.12.2016Examination fee paid 
Examination procedure28.12.2016Examination requested  [2017/24]
28.12.2016Date on which the examining division has become responsible
27.11.2018Communication of intention to grant the patent
28.02.2019Fee for grant paid
28.02.2019Fee for publishing/printing paid
28.02.2019Receipt of the translation of the claim(s)
Opposition(s)13.01.2020No opposition filed within time limit [2020/12]
Fees paidRenewal fee
22.08.2017Renewal fee patent year 03
28.08.2018Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAL10.04.2019
AT10.04.2019
CY10.04.2019
CZ10.04.2019
DK10.04.2019
EE10.04.2019
FI10.04.2019
HR10.04.2019
LT10.04.2019
LV10.04.2019
MC10.04.2019
MK10.04.2019
MT10.04.2019
NL10.04.2019
PL10.04.2019
RO10.04.2019
RS10.04.2019
SE10.04.2019
SI10.04.2019
SK10.04.2019
SM10.04.2019
TR10.04.2019
BG10.07.2019
NO10.07.2019
GR11.07.2019
LU03.08.2019
IS10.08.2019
PT10.09.2019
[2022/32]
Former [2021/34]AL10.04.2019
AT10.04.2019
CY10.04.2019
CZ10.04.2019
DK10.04.2019
EE10.04.2019
FI10.04.2019
HR10.04.2019
LT10.04.2019
LV10.04.2019
MC10.04.2019
MT10.04.2019
NL10.04.2019
PL10.04.2019
RO10.04.2019
RS10.04.2019
SE10.04.2019
SI10.04.2019
SK10.04.2019
SM10.04.2019
TR10.04.2019
BG10.07.2019
NO10.07.2019
GR11.07.2019
LU03.08.2019
IS10.08.2019
PT10.09.2019
Former [2021/26]AL10.04.2019
AT10.04.2019
CY10.04.2019
CZ10.04.2019
DK10.04.2019
EE10.04.2019
FI10.04.2019
HR10.04.2019
LT10.04.2019
LV10.04.2019
MC10.04.2019
NL10.04.2019
PL10.04.2019
RO10.04.2019
RS10.04.2019
SE10.04.2019
SI10.04.2019
SK10.04.2019
SM10.04.2019
TR10.04.2019
BG10.07.2019
NO10.07.2019
GR11.07.2019
LU03.08.2019
IS10.08.2019
PT10.09.2019
Former [2020/25]AL10.04.2019
AT10.04.2019
CZ10.04.2019
DK10.04.2019
EE10.04.2019
FI10.04.2019
HR10.04.2019
LT10.04.2019
LV10.04.2019
MC10.04.2019
NL10.04.2019
PL10.04.2019
RO10.04.2019
RS10.04.2019
SE10.04.2019
SI10.04.2019
SK10.04.2019
SM10.04.2019
TR10.04.2019
BG10.07.2019
NO10.07.2019
GR11.07.2019
LU03.08.2019
IS10.08.2019
PT10.09.2019
Former [2020/17]AL10.04.2019
AT10.04.2019
CZ10.04.2019
DK10.04.2019
EE10.04.2019
FI10.04.2019
HR10.04.2019
LT10.04.2019
LV10.04.2019
NL10.04.2019
PL10.04.2019
RO10.04.2019
RS10.04.2019
SE10.04.2019
SK10.04.2019
SM10.04.2019
TR10.04.2019
BG10.07.2019
NO10.07.2019
GR11.07.2019
IS10.08.2019
PT10.09.2019
Former [2020/14]AL10.04.2019
AT10.04.2019
CZ10.04.2019
DK10.04.2019
EE10.04.2019
FI10.04.2019
HR10.04.2019
LT10.04.2019
LV10.04.2019
NL10.04.2019
PL10.04.2019
RO10.04.2019
RS10.04.2019
SE10.04.2019
SK10.04.2019
SM10.04.2019
BG10.07.2019
NO10.07.2019
GR11.07.2019
IS10.08.2019
PT10.09.2019
Former [2020/11]AL10.04.2019
AT10.04.2019
CZ10.04.2019
DK10.04.2019
EE10.04.2019
FI10.04.2019
HR10.04.2019
LT10.04.2019
LV10.04.2019
NL10.04.2019
PL10.04.2019
RO10.04.2019
RS10.04.2019
SE10.04.2019
SK10.04.2019
BG10.07.2019
NO10.07.2019
GR11.07.2019
IS10.08.2019
PT10.09.2019
Former [2020/10]AL10.04.2019
AT10.04.2019
CZ10.04.2019
DK10.04.2019
FI10.04.2019
HR10.04.2019
LT10.04.2019
LV10.04.2019
NL10.04.2019
PL10.04.2019
RO10.04.2019
RS10.04.2019
SE10.04.2019
BG10.07.2019
NO10.07.2019
GR11.07.2019
IS10.08.2019
PT10.09.2019
Former [2020/09]AL10.04.2019
AT10.04.2019
CZ10.04.2019
DK10.04.2019
FI10.04.2019
HR10.04.2019
LT10.04.2019
LV10.04.2019
NL10.04.2019
PL10.04.2019
RS10.04.2019
SE10.04.2019
BG10.07.2019
NO10.07.2019
GR11.07.2019
IS10.08.2019
PT10.09.2019
Former [2020/04]AL10.04.2019
AT10.04.2019
FI10.04.2019
HR10.04.2019
LT10.04.2019
LV10.04.2019
NL10.04.2019
PL10.04.2019
RS10.04.2019
SE10.04.2019
BG10.07.2019
NO10.07.2019
GR11.07.2019
IS10.08.2019
PT10.09.2019
Former [2020/03]AL10.04.2019
AT10.04.2019
FI10.04.2019
HR10.04.2019
LT10.04.2019
LV10.04.2019
NL10.04.2019
PL10.04.2019
RS10.04.2019
SE10.04.2019
BG10.07.2019
NO10.07.2019
GR11.07.2019
PT10.09.2019
Former [2019/52]AL10.04.2019
FI10.04.2019
HR10.04.2019
LT10.04.2019
LV10.04.2019
NL10.04.2019
PL10.04.2019
RS10.04.2019
SE10.04.2019
BG10.07.2019
NO10.07.2019
GR11.07.2019
PT10.09.2019
Former [2019/51]AL10.04.2019
FI10.04.2019
HR10.04.2019
LT10.04.2019
LV10.04.2019
NL10.04.2019
RS10.04.2019
SE10.04.2019
BG10.07.2019
NO10.07.2019
GR11.07.2019
PT10.09.2019
Former [2019/50]AL10.04.2019
FI10.04.2019
HR10.04.2019
LT10.04.2019
LV10.04.2019
NL10.04.2019
RS10.04.2019
SE10.04.2019
NO10.07.2019
GR11.07.2019
PT10.09.2019
Former [2019/49]AL10.04.2019
FI10.04.2019
HR10.04.2019
LT10.04.2019
NL10.04.2019
SE10.04.2019
NO10.07.2019
PT10.09.2019
Former [2019/48]FI10.04.2019
LT10.04.2019
NL10.04.2019
SE10.04.2019
NO10.07.2019
PT10.09.2019
Former [2019/47]FI10.04.2019
LT10.04.2019
NL10.04.2019
NO10.07.2019
Former [2019/44]NL10.04.2019
Documents cited:Search[A]EP2626350  (EISAI R&D MAN CO LTD [JP]) [A] 1* page 42 - page 43 *
International search[A]JPS59184167  (BAYER AG) [A] 1-7* , entire text & US 4552900 A & EP 123861 A2 *;
 [A]JPS6169762  (BAYER AG) [A] 1-7 * , entire text & EP 177710 A1 *;
 [Y]JPS6229266  (MATSUSHITA GRAPHIC COMMUNIC) [Y] 2-5 * , page 2 (Family: none) *;
 [Y]JPS62292767  (TEIKOKU CHEM IND CO LTD, et al) [Y] 2-5 * , page 2 (Family: none) *;
 [Y]JPH03220133  (FUJI PHOTO FILM CO LTD) [Y] 1-7 * , page 3; examples 4, 9 & US 5117064 A column 2 *;
 [Y]WO03016275  (SHIONOGI & CO [JP], et al) [Y] 2-5 * , pages 291 to 292 & US 2004/0229909 A1 page 114 & JP 2009-161556 A & JP 2012-236852 A & EP 1422218 A1 & EP 2181985A1 & EP 2266958 A1 & KR 10-0977701 B1 & CN 1558898 A & CN 101513402 A & KR 10-2010-0087209 A *;
 [Y]WO2012039371  (EISAI R&D MAN CO LTD [JP], et al) [Y] 1-7 * , preparation example 4 & US 2012/0095031 A1 production example 4 & JP 4944286 B & EP 2626350 A1 & CN 103153963 A & KR 10-2013-0097776 A *;
 [Y]  - LIPINSKI, C.A. et al., "Bronchodilator and antiulcer phenoxypyrimidinones", Journal of Medicinal Chemistry, (19800000), vol. 23, doi:doi:10.1021/jm00183a012, ISSN 0022-2623, pages 1026 - 1031, XP002201971 [Y] 2-5 * , scheme 1 *

DOI:   http://dx.doi.org/10.1021/jm00183a012
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.